277 related articles for article (PubMed ID: 16766332)
1. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
[TBL] [Abstract][Full Text] [Related]
2. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
3. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
Nikkels AF; Piérard GE
J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
[No Abstract] [Full Text] [Related]
4. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
Strober BE; Clarke S
J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with acitretin for psoriasis.
Hodulik SG; Zeichner JA
J Dermatolog Treat; 2006; 17(2):108-11. PubMed ID: 16766335
[TBL] [Abstract][Full Text] [Related]
6. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
Smith EC; Riddle C; Menter MA; Lebwohl M
Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
[TBL] [Abstract][Full Text] [Related]
7. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
[No Abstract] [Full Text] [Related]
8. Acitretin is a safe treatment option for infantile pustular psoriasis.
Ergin S; Ersoy-Evans S; Sahin S; Ozkaya O
J Dermatolog Treat; 2008; 19(6):341-3. PubMed ID: 18608713
[TBL] [Abstract][Full Text] [Related]
9. A treatment strategy for psoriasis: transitioning from systemic therapy to biologic agents.
Ortiz A; Yamauchi PS
Skinmed; 2006; 5(6):285-8. PubMed ID: 17085995
[TBL] [Abstract][Full Text] [Related]
10. The successful use of etanercept in combination therapy for treatment of acrodermatitis continua of hallopeau.
Kazinski K; Joyce KM; Hodson D
J Drugs Dermatol; 2005; 4(3):360-4. PubMed ID: 15898294
[TBL] [Abstract][Full Text] [Related]
11. Acitretin for the treatment of psoriasis: an assessment of national trends.
Ghasri P; Yentzer BA; Dabade TS; Feldman SR
J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
[TBL] [Abstract][Full Text] [Related]
12. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis.
Yelverton CB; Yentzer BA; Clark A; Pearce DJ; Balkrishnan R; Camacho FT; Boles A; Fleischer AB; Feldman SR
Arch Dermatol; 2008 Sep; 144(9):1224-5. PubMed ID: 18794474
[No Abstract] [Full Text] [Related]
13. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis.
Ezquerra GM; Regaña MS; Millet PU
Acta Derm Venereol; 2007; 87(5):449-50. PubMed ID: 17721663
[No Abstract] [Full Text] [Related]
14. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
[TBL] [Abstract][Full Text] [Related]
15. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
Silpa-archa N; Wongpraparut C
J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
[TBL] [Abstract][Full Text] [Related]
16. Intermittent dosing of biologics for psoriasis.
Feldman SR
J Dermatolog Treat; 2006; 17(1):5. PubMed ID: 16467016
[No Abstract] [Full Text] [Related]
17. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
18. Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
Krell JM
J Am Acad Dermatol; 2006 Jun; 54(6):1099-101. PubMed ID: 16713481
[TBL] [Abstract][Full Text] [Related]
19. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
Young MS; Horn EJ; Cather JC
Expert Rev Clin Immunol; 2011 Jan; 7(1):9-13. PubMed ID: 21162644
[TBL] [Abstract][Full Text] [Related]
20. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
